If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProvexis Regulatory News (PXS)

Share Price Information for Provexis (PXS)

Share Price is delayed by 15 minutes
Get Live Data
1.29    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.08 (6.40%)
Market Cap: £30.26m
PXS Live PriceLast checked at - London Stock Exchange

Intraday Provexis Share Chart

Directorate Change

4 May 2007 14:35

Provexis PLC04 May 2007 4 May 2007 PROVEXIS PLC ("Provexis" or the "Company") Directorate Change Provexis plc (ticker PXS.L), the nutraceutical company that developsscientifically-proven functional and medical foods, has appointed Jonathan BrettDiggines to its Board as a non-executive director with immediate effect. Jonathan Diggines, 54, is Chief Executive Officer of Enterprise Ventures GroupLimited, a 19.4 per cent shareholder in the Company. Jonathan, who is asolicitor, joined Enterprise Ventures in 2005 and had previously spent 10 yearsas Managing Director of Murray Johnstone Private Equity where he managedsubstantial private equity and venture funds. Jonathan holds or has held thefollowing directorships or been a partner in the following partnerships withinthe five years prior to this announcement: • Enterprise Ventures (General Partner Coalfields) Limited • Enterprise Ventures (General Partner EVF/LEV) Limited • Enterprise Ventures (General Partner HSBC European Fund) Limited • Enterprise Ventures (General Partner HSBC UK Enterprise Fund) Limited • Enterprise Ventures (General Partner Rising Stars) Limited • Enterprise Ventures (General Partner Rising Stars II) Limited • Enterprise Ventures Limited • Enterprise Ventures Group Limited • Enterprise Ventures Nominees Limited • LE Founders Limited • LE Founders II Limited • LE Founders III Limited • Nichols plc • North West Enterprise Investment Limited • Rising Stars Growth Fund Limited • Carbutt & Co. (1928) Limited • LE Founders Limited • MJPAP (Syndications) Limited • MJPAP II (Syndications) Limited • T F Willow Limited • Weigh A Way Limited • W F P Willow Limited • W G Willow Limited • W I Willow Limited • W Willow Limited • British Venture Capital Association • RAL (S&G) Limited • Sumit Venture Fund One Limited • STF Management Limited • SEV Investments Limited • SEV Holdings Limited • BIG (General Partner) Limited • Regent Street Ventures Limited • Aberdeen Murray Johnstone Private Equity Limited • Euractions Management Limited • Murray Johnstone Limited • Callform Limited • Aberdeen Growth Opportunities VCT PLC • M J Founders Limited • COIP (GB) Limited • Aberdeen Asset Managers Limited • AMJPEF Founder Partner Limited • AMJPEF GP Limited There are no further disclosures to be made in accordance with Schedule 2(g) ofthe AIM Rules. Dawson Buck, Chairman of Provexis said: "I am delighted that Jonathan Diggineshas joined the Board of Provexis. He brings a considerable wealth of experiencegained from his management of venture funds and from his portfolio ofnon-executive director roles both in public and private companies, including anumber of significant food and drink sector investments. These attributescombined with his standing in the private equity and venture capital industrywill add significant value to the strategic development of our proprietarytechnologies." - ENDS - Enquiries: Provexis PlcStephen Moon, Chief Executive Officer 020 8392 6634 Arbuthnot SecuritiesTom GriffithsAlasdair Younie 020 7012 2000 Adventis Financial PRChris Steele 020 7034 4759Annie Evangeli 020 7034 4757 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
5th Jun 20174:35 pmRNSPrice Monitoring Extension
19th May 20174:40 pmRNSSecond Price Monitoring Extn
19th May 20174:35 pmRNSPrice Monitoring Extension
10th May 20177:01 amRNSTrading Update
10th May 20177:00 amRNSResults of Placing
2nd May 20177:15 amRNSFunding Update
11th Apr 20174:40 pmRNSSecond Price Monitoring Extn
11th Apr 20174:35 pmRNSPrice Monitoring Extension
6th Apr 20177:00 amRNSBy-Health MOU and product launch for Fruitflow
8th Feb 20174:40 pmRNSSecond Price Monitoring Extn
8th Feb 20174:35 pmRNSPrice Monitoring Extension
30th Dec 20167:00 amRNSHalf-year Report
21st Dec 20164:41 pmRNSSecond Price Monitoring Extn
21st Dec 20164:35 pmRNSPrice Monitoring Extension
20th Dec 20167:00 amRNSFruitflow and Blood Pressure - second stage update
23rd Nov 20167:00 amRNSStudy publication - comparison with aspirin
18th Nov 20169:46 amRNSNew Collaboration for Fruitflow
30th Sep 20163:33 pmRNSResult of AGM
15th Sep 20165:08 pmRNSDirector/PDMR Shareholding
7th Sep 20167:00 amRNSPreliminary Results
2nd Sep 201610:23 amRNSHolding(s) in Company
2nd Aug 20167:00 amRNSResults of Placing
12th Jul 20167:00 amRNSStudy Publication
29th Jun 20167:05 amRNSFunding Update
29th Jun 20167:00 amRNSProduct Launch
9th Jun 20162:29 pmRNSFunding Update
31st May 20167:00 amRNSTrading Update
11th Apr 20164:40 pmRNSSecond Price Monitoring Extn
11th Apr 20164:35 pmRNSPrice Monitoring Extension
25th Feb 20164:40 pmRNSSecond Price Monitoring Extn
25th Feb 20164:35 pmRNSPrice Monitoring Extension
19th Feb 20164:40 pmRNSSecond Price Monitoring Extn
19th Feb 20164:35 pmRNSPrice Monitoring Extension
7th Jan 20162:01 pmRNSDirector/PDMR Shareholding
22nd Dec 20157:00 amRNSHalf Yearly Report
30th Sep 20154:58 pmRNSResult of AGM
7th Sep 201510:47 amRNSAnnual Report and Notice of AGM
4th Sep 20157:00 amRNSPreliminary Results
21st Jul 20153:41 pmRNSHolding(s) in Company
3rd Jul 20157:00 amRNSPlacing of shares via Primarybid.com
29th Jun 20157:00 amRNSUpdate of Collaboration with University of Oslo
4th Jun 20157:00 amRNSEnhanced terms for Fruitflow Alliance Agreement
24th Apr 20154:35 pmRNSPrice Monitoring Extension
20th Feb 20152:34 pmRNSFruitflow - New Product Video
19th Jan 20154:40 pmRNSSecond Price Monitoring Extn
19th Jan 20154:35 pmRNSPrice Monitoring Extension
30th Dec 20147:00 amRNSHalf Yearly Report
9th Dec 20147:00 amRNSDraw Down of Funds and Issue of Equity
1st Dec 20147:00 amRNSRe-appointment to the Scientific Advisory Board
18th Nov 20147:00 amRNSCollaboration with the University of Oslo

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.